(Total Views: 396)
Posted On: 06/17/2019 1:46:35 PM
Post# of 155136
New PI Video:
https://www.proactiveinvestors.com/companies/...13768.html
Summary:
1) NP is back in the office
2) Discusses PrEP Thai study; could very quick process to prevention approval (post combo approval); seems like they are trying to put the pressure on Gilead; less side affects on Leronlimab compared to Truvada.
3) Trial outline: 50 patients initially potentially from large center that tests 40,000 patients checked on regular basis; protocol still in design; hope to begin study this year.
https://www.proactiveinvestors.com/companies/...13768.html
Summary:
1) NP is back in the office
2) Discusses PrEP Thai study; could very quick process to prevention approval (post combo approval); seems like they are trying to put the pressure on Gilead; less side affects on Leronlimab compared to Truvada.
3) Trial outline: 50 patients initially potentially from large center that tests 40,000 patients checked on regular basis; protocol still in design; hope to begin study this year.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
